Table 1.
MNL | PMNL | Total | |
---|---|---|---|
Control | 2.4±0.4 | 0.7±0.1 | 3.1±0.4 |
PBS+LPS/Gal | 3.1±0.4 | 1.6±0.2 | 4.8±0.6 |
LFA-1−/−+LPS/Gal | 4.5±1.5 | 1.7±0.3 | 6.2±1.6 |
Control ab+LPS/Gal | 3.0±0.4 | 1.2±0.4 | 4.2±0.6 |
Anti-LFA-1 ab+LPS/Gal | 4.6±1.0 | 1.0±0.2 | 5.6±1.2 |
Leukocytes were counted in a hematocytometer and defined as mononuclear (MNL) or polymorphonuclear (PMNL). Animals received a combination of LPS (10 μg) and D-galactosamine (Gal, 18 mg) in wild-type or LFA-1-deficient mice (−/−). Negative control animals received PBS (Control). Animals were pretreated with a monoclonal antibody against LFA-1 (M17/4.4.11.9, 100 μg per mouse) and a control antibody (9-A2, 100 μg per mouse) or PBS. Data represent means±s.e.m., and n=5–8.